Skip to main content
[Preprint]. 2021 Jan 27:2021.01.27.427998. [Version 1] doi: 10.1101/2021.01.27.427998

Figure 1. PRNT50s of twenty BNT162b2-vaccinated human sera against wild-type (WT) and mutant SARS-CoV-2.

Figure 1.

(a) WT (USA-WA1/2020) and mutant N501Y. (b) WT and Δ69/70+N501Y+D614G. (c) WT and E484K+N501Y+D614G. Seven (triangles) and thirteen (circles) sera were drawn 2 and 4 weeks after the second dose of vaccination, respectively. Sera with different PRNT50s against WT and mutant viruses are connected by lines. Results in (a) were from one experiment; results in (b) and (c) were from another set of experiments. Each data point is the average of duplicate assay results.